Introduction Chlamydia trachomatis is the most common sexually transmitted bacterial
pathogen in the world. Antibiotic treatment does not prevent against reinfection and a …

Introduction Chlamydia trachomatis is the most common sexually transmitted bacterial
pathogen in the world. A licensed vaccine is not yet available, but the first vaccines have …

Chlamydiosis is a significant disease affecting Eastern Australian koala (Phascolarctos
cinereus) populations, impacting individual animal welfare and fecundity and therefore …

The requirement for vaccine-induced tissue-resident immunity for protection against one or
repeated infections with Chlamydia trachomatis (Ct) is still not fully resolved. In this study …

The clinical development of an effective Chlamydia vaccine requires in-depth understanding
of how well protective pre-clinical immune signatures translate to humans. Here, we report a …

There is an urgent need to produce a vaccine for Chlamydia trachomatis infections. Here,
using the Chlamydia muridarum major outer membrane protein (MOMP) as an antigen, four …

Ureaplasma urealyticum (U. urealyticum, Uu) is a common sexually transmitted pathogen
that is responsible for diseases such as non-gonococcal urethritis, chorioamnionitis, and …

The bacterial outer membrane proteins are important components of bacterial cell.
Edwardsiella tarda is a vital bacterial pathogen to a wide range of aquaculture animals. In …

Chlamydia trachomatis is a sexually transmitted bacterium that infects over 130 million
individuals worldwide annually. To implement a vaccine, we developed a cell-free co …

Abstract Toll-like receptor 9 (TLR9) is an innate immune receptor that localizes to
endosomes in antigen presenting cells and recognizes single stranded unmethylated CpG …